The environment

With climate change causing an alarming number of negative health impacts – from respiratory disease due to air pollution to the spread of malaria resulting from deforestation – Roche sees tackling climate change as integral to its purpose as a global business. We are taking concrete action to fight climate change and protect our planet now and in the future. We will continue to review our targets and strategy, and invest in innovation, to reach zero emissions as quickly as possible.

Reducing our carbon emissions in the UK

Roche is committed to reducing our carbon emissions across Scopes 1 and 2 to absolute zero by 2050 and to ensure we more than support the Paris Goal of 1.5 degrees, which we are on track to do.

In the UK, Roche has reduced CO2 emissions per employee by a quarter, and we have reduced energy use by twice that of the average firm in the UK.1

Roche has reduced CO2 emissions per employee by a quarter in the UK

Reduction in CO2 emissions per employee across the two Roche locations in the UK from 2014-20191
Table 1 - emissions

Roche has reduced energy use by twice that of the average firm in the UK

Reduction in energy consumption per employee across the two Roche locations in the UK from 2014-20193
Table 2 - emissions

Reduction in greenhouse gas emissions globally

Roche has been measuring and monitoring its total environmental impact for over 15 years, and through rigorous analysis, we create strategies based on the science to improve efficiencies across our business and supply chain and ultimately drive down GHG emissions. We have not delayed action in the past, and we will not delay action now.

75 percent reduction icon

Between 1990 and 2020, we have reduced our greenhouse gas (GHG emissions) by 75%, and We believe we can achieve an absolute carbon reduction of 94% by 2030 against our 1990 baseline.

Our reporting

Roche is committed to transparent reporting, and we endeavour to drive our economic, social and environmental performance with the same diligence as our financial performance. You can learn more here.

Diversity and inclusion

At Roche, we want to be recognised for being the best place to work. Our environment is one where people are empowered and can bring their authentic selves. We foster a culture where everyone can thrive and flourish. We want to keep driving to ensure our workforce is a true representation of the society we serve.

Sustainability in procurement practices

 

1.26 billion icon

In the UK, Roche supports over 21,000 jobs through business activities, supply chain and employee spending, contributing £1.2 billion to the UK economy in 2020. In order to deliver on our commitments, we work closely with all of our suppliers and support them as much as possible to build capability and manage their emissions. Examples include:

  • Supporting our suppliers in capturing and progressing data on their carbon emissions, including a pilot project to offer all our suppliers renewable energy at Roche’s discounted rate, with the goal of having all our suppliers run on 100% renewable energy.
  • Working with Manufacture 2030 to assist suppliers with the reporting of their emissions as part of our 10-year global ambition to reduce our overall environmental footprint by 50%.

UK Eco Crew

We also have an Eco Crew, a group of Roche UK employees who aim to educate and inspire colleagues, and contribute to site and global sustainability initiatives, as well as running local ones. 

Since the Eco Crew was founded in 2019, they have been instrumental in initiatives like reducing the amount of single use plastic on site, the role out of ESG pensions and challenging colleagues to bring more sustainable options into their day-to-day life (e.g. Plastic Free July and Greener Christmas challenges, which 80+ colleagues took part in).

96 percent image

Health inequalities

Healthcare matters to all of us and doesn’t discriminate. That’s why we work hard to ensure that all our new medicines and tests are made available to those who need them through the NHS - wherever they live, whatever their circumstances.

Sadly, there are still many health inequalities across the UK. For example, a recent report sponsored by Roche Diagnostics illustrates several ‘hidden victims’ of heart failure, including female patients who are 96% more likely to be misdiagnosed than men.5 

We partner with the wider UK health ecosystem with the aim of delivering, for all eligible patients, universal access to our medicines and tests. For example, we have been spearheading the collaboration with the AHSNs, NICE and NHS to deliver on the adoption of a NICE recommended test for the assessment of preeclampsia in pregnant women. 

Tackling global health inequalities 

Universal access to quality healthcare and medical innovation remains a global challenge.  To address this challenge, many of the world’s top relief and aid organisations have joined together with an ambitious goal: to eliminate many diseases.  In support of this ambition, Roche Diagnostics launched a Global Access Program which provides access to diagnostics for HIV, hepatitis, tuberculosis and cervical cancer (HPV), in high disease burden and qualified countries where reliable diagnostic solutions are needed most.

References

  1. Provided by Safety, Health & Environment (SHE) team at Roche Products, Roche Diagnostics and Roche Diabetes Care
  2. UK Greenhouse gas emissions by SIC 1990-2019 - Department for Business, Energy & Industrial Strategy
  3. Provided by Safety, Health & Environment (SHE) team at Roche Products, Roche Diagnostics and Roche Diabetes Care
  4. UK energy use: by industry, source, and fuel - Office for National Statistics
  5. https://hfreport.roche.com/home

M-GB-00007185 Date of Preparation June 2022